Skip to main content
OpenTrials

Clinical trial condition

HER2/Neu Negative

Explore clinical trials studying HER2/Neu Negative. Study availability and eligibility vary by location and protocol.

56 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

HER2/Neu Negative trial results

Active, not recruiting

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

NCT02488967

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Southern Cancer Center PC-Springhill Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
View all 1296 locations
View Trial Details
Active, not recruiting

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

NCT02744053

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +8 more
Locations
  • Memorial Hermann Memorial City Medical Center Houston, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson League City Nassau Bay, Texas, United States
View Trial Details
Completed

Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer

NCT02860000

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Status, +12 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

NCT01750073

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +20 more
Locations
  • Nebraska Medicine-Bellevue Bellevue, Nebraska, United States
  • CHI Health Saint Francis Grand Island, Nebraska, United States
  • Nebraska Medicine-Village Pointe Cancer Center Omaha, Nebraska, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

NCT00785291

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Sparks Regional Medical Center Fort Smith, Arkansas, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
View all 704 locations
View Trial Details

Related conditions